1155264-46-2

Basic information

• Product Name: 2H-1,4-Benzoxazine, 3,4-dihydro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
• Synonyms: 2H-1,4-Benzoxazine, 3,4-dihydro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;3,4-Dihydro-6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-2H-benzo[b][1,4]oxazine;6-(tetraMethyl-1,3,2-dioxaborolan-2-yl)-3,4- dihydro-2H-1,4-benzoxazine;6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine;3,4-Dihydro-2H-1,4-benzoxazine-6-boronic acid pinacol ester;6-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-3,4-dihydro-2H-benzo[1,4]oxazine;(3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZIN-6-YL)BORONIC ACID PINACOL ESTER
• CAS NO: 1155264-46-2
• Molecular Formula: C14H20BNO3
• Molecular Weight: 261.1245
• Mol File: 1155264-46-2.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 387.6±42.0 °C(Predicted)
• Appearance: /Solid
• Density: 1.12±0.1 g/cm3(Predicted)
• PKA: 4.46±0.20(Predicted)
• CAS DataBase Reference: 2H-1,4-Benzoxazine, 3,4-dihydro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2H-1,4-Benzoxazine, 3,4-dihydro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-(1155264-46-2)
• EPA Substance Registry System: 2H-1,4-Benzoxazine, 3,4-dihydro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-(1155264-46-2)

Safety Data

• Hazardous Substances Data: 1155264-46-2(Hazardous Substances Data)

Usage

General Description

The chemical "2H-1,4-Benzoxazine, 3,4-dihydro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-" is a complex compound that belongs to the benzoxazine family. It is a 3,4-dihydro derivative with a boron-containing functional group attached to the 6th position. This chemical may have potential applications in the fields of chemistry, material science, and pharmaceuticals due to its unique structure and properties. Additionally, the boron-containing group may offer opportunities for further functionalization and modification, making it a versatile building block for the synthesis of new compounds with specific properties and applications.

Upstream product

• 138035-68-4 5-chloro-2H-benzo[b][1,4]oxazin-3(4H)-one 
• 56962-00-6 2-amino-3-chlorophenol 
• 64182-61-2 1-chloro-3-fluoro-2-nitrobenzene 
• 17802-02-7 2-nitro-3-chlorophenol 
• 1154740-66-5 6-bromo-5-chloro-2H-1,4-benzoxazin-3(4H)-one 
• 1154740-67-6 C₈H₇BrClNO 
• 7693-52-9 4-bromo-2-nitrophenol 
• 40925-68-6 2-amino-4-bromo-phenol 
• 24036-52-0 6-bromo-3,4-dihydro-2H-1,4-benzoxazin-3-one 
• 105655-01-4 6-bromo-3, 4-dihydro-2H-benzo[β][1, 4]oxazine 
• 73183-34-3 bis(pinacol)diborane 
• 1154740-68-7 5-chloro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine 

Downstream Products

• 1256254-54-2 C₃₀H₃₆N₂O₄ 
• 1256250-76-6 C₂₉H₃₄N₂O₄ 

Relevant articles and documents

SINGLE MOLECULE COMPOUNDS PROVIDING MULTI-TARGET INHIBITION OF BTK AND OTHER PROTEINS AND METHODS OF USE THEREOF

The invention relates to compounds useful for inhibiting BTK and at least one other protein and to methods of treating diseases including cancer by administration of a compound(s) of Formula I-IV or pharmaceutically acceptable salts thereof as defined her

SYK INHIBITORS

The present disclosure a Syk compound inhibitors, including state cancer and inflammation and various disease States thereof in the treatment of relates to the use of. In one aspect a particular embodiment, . given by formula I which is marked as a chemical structure of compound. In formula said, X 1, X 2, X 3, R 2, R 3, R 4, R 5, and Y has described herein is. The present disclosure of a formula I compounds or a pharmaceutically acceptable salt of pharmaceutical compositions including, mediated by Syk and to treat conditions a employing these compounds and compositions further provides a method. (by machine translation)

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of formula I wherein a, R1, R2, R3, R4, R5 and R6 are defined herein, are useful as inhibitors of HIV replication.